Larry Ereshefsky
Impact in
- Family Practice top 0.5%
- Medication Adherence and Compliance
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Pharmacy and Medical Practices
Papers in
- Pharmacology 31
- Pharmacogenetics and Drug Metabolism 26
- Treatment of Major Depression 15
- Pharmacy and Medical Practices 5
-
- Schizophrenia research and treatment 31
- Dementia and Cognitive Impairment Research 3
- Bipolar Disorder and Treatment 3
- Co-authors
- Y. W. Francis Lam (14 shared papers)Stephen R. Saklad (19 shared papers)Michael W. Jann (14 shared papers)Cara L. Alfaro (6 shared papers)Chester M. Davis (7 shared papers)Alexander L. Miller (6 shared papers)David C. Glahn (2 shared papers)NEIL R. BURCH (4 shared papers)
- Journals
- Alzheimer s & Dementia (14 papers)Schizophrenia Research (7 papers)Annals of Pharmacotherapy (7 papers)Journal of Clinical Psychopharmacology (7 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (5 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Larry Ereshefsky
135 papers receiving 5.6k citations
Larry Ereshefsky's Hit Papers
Peers
Comparison fields: 5 of 87
- Family Practice 360
- Pharmacology 875
- Psychiatry and Mental health 1.5k
- Physiology 899
- Pharmacology 356
Countries citing papers authored by Larry Ereshefsky
This map shows the geographic impact of Larry Ereshefsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Ereshefsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Ereshefsky more than expected).
Fields of papers citing papers by Larry Ereshefsky
This network shows the impact of papers produced by Larry Ereshefsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Ereshefsky. The network helps show where Larry Ereshefsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Larry Ereshefsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients Hit paper breakdown → | 2016 | 377 |
| 2 | 2011 | 330 | |
| 3 | 2005 | 251 | |
| 4 | 2007 | 205 | |
| 5 | 2004 | 195 | |
| 6 | Pharmacokinetics and drug interactions: update for new antipsychotics. | 1996 | 189 |
| 7 | 2015 | 174 | |
| 8 | 2007 | 140 | |
| 9 | 2008 | 131 | |
| 10 | 2021 | 128 | |
| 11 | 1995 | 125 | |
| 12 | 2000 | 121 | |
| 13 | 2007 | 116 | |
| 14 | 1985 | 115 | |
| 15 | Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics. | 2003 | 110 |
| 16 | 2003 | 107 | |
| 17 | 1985 | 103 | |
| 18 | 1986 | 102 | |
| 19 | 1985 | 98 | |
| 20 | 1996 | 94 |
About Larry Ereshefsky
Larry Ereshefsky is a scholar working on Pharmacology, Psychiatry and Mental health, Pharmacology, Physiology and Family Practice, having authored 138 papers that have together received 6.2k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (31 papers), Pharmacogenetics and Drug Metabolism (26 papers), Alzheimer's disease research and treatments (18 papers), Treatment of Major Depression (15 papers), Medication Adherence and Compliance (6 papers), Pharmacy and Medical Practices (5 papers), Dementia and Cognitive Impairment Research (3 papers) and Bipolar Disorder and Treatment (3 papers). The work is most often cited by research in Family Practice (360 citations), Pharmacology (875 citations), Psychiatry and Mental health (1.5k citations), Physiology (899 citations) and Pharmacology (356 citations). Larry Ereshefsky has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Y. W. Francis Lam, Stephen R. Saklad, Michael W. Jann, Cara L. Alfaro, Chester M. Davis, Alexander L. Miller, David C. Glahn, NEIL R. BURCH, Ann L. Richards and Natalie J. Maples. Their work appears in journals such as Alzheimer s & Dementia, Schizophrenia Research, Annals of Pharmacotherapy, Journal of Clinical Psychopharmacology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.